Thank you for your interest in donating COVID-19 convalescent plasma. People who have recovered from COVID-19 have antibodies to the coronavirus in their plasma that can help patients still fighting COVID-19.
Convalescent plasma donors MUST be at least 14 days symptom free. Please DO NOT present to donate if you have a fever or experiencing flu like symptoms.Ver página en español
If you have recently donated at OneBlood and had an COVID-19 antibody positive test result, we will simply need to verify your record and can get you scheduled to donate convalescent plasma. Call 407-858-4939 to speak with our convalescent plasma team.
If you are a physician or clinician with a potential COVID-19 convalescent plasma donor, please follow our clinician intake path here.
COVID-19 convalescent plasma is plasma collected from people who have recovered from COVID-19. People who recover from COVID-19 have developed antibodies to the coronavirus that remain in the plasma portion of their blood. Transfusing the plasma that contains the antibodies into a person still fighting the disease can provide a boost to the patient’s immune system and potentially help them recover. COVID-19 convalescent plasma is a treatment that the Food and Drug Administration (FDA) has granted emergency use authorization to use in treating COVID-19 patients.
The amount of collected plasma does not negatively impact your immune system.
Once your pre-registration is complete and a OneBlood team member has determined you meet all required screening criteria to be a donor, you will be contacted to schedule your donation. If you have been fully pre-screened and have not been scheduled after 24 hours, please call 407-858-4939 to get in touch with our response team.
Donors who tested positive for the COVID-19 antibody during a prior OneBlood donation can skip the pre-registration process to be a convalescent plasma donor. These donors can call our convalescent plasma concierge line at 407-858-4939 and our team will assist them in scheduling an appointment.
People who have recovered from COVID-19 develop antibodies to the coronavirus that remain in the plasma portion of their blood. Studies have shown that by transfusing the plasma from a person who has recovered from COVID-19, into a patient still fighting the disease, it can help boost the patient’s immune system and potentially help them recover. The treatment is known as, COVID-19 convalescent plasma.
COVID-19 convalescent plasma is a treatment that the U.S. Food and Drug Administration (FDA) has granted emergency use authorization to use in treating COVID-19 patients. With no cure or vaccine to prevent the coronavirus, doctors are turning to convalescent plasma to help treat COVID-19 patients and are seeing promising results.
Only people who have recovered from COVID-19 have the potential of being a convalescent plasma donors.
OneBlood began collecting convalescent plasma in April 2020 and will continue to do so for the foreseeable future. OneBlood distributes COVID-19 convalescent plasma 24 hours a day seven days a week to hospitals throughout the Southeastern United States.
In addition to local efforts, OneBlood has been working closely with the federal government since the beginning of the pandemic to assist in efforts to create a national inventory of COVID-19 convalescent plasma.
OneBlood is also testing all blood donations for the COVID-19 antibody. Donors who test positive for the antibody have the potential of becoming COVID-19 convalescent plasma donors.